Moviprep and Flatulence - a phase IV clinical study of FDA data

Summary:

Flatulence is reported as a side effect among people who take Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Calcium, and have Ulcerative colitis.

The phase IV clinical study analyzes which people have Flatulence when taking Moviprep. It is created by eHealthMe based on reports of 3,148 people who have side effects when taking Moviprep from the FDA, and is updated regularly.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

What is Flatulence?

Flatulence (flatus expelled through the anus) is found to be associated with 1,792 drugs and 1,889 conditions by eHealthMe. Check the latest studies of Flatulence.

On Apr, 22, 2026

3,148 people reported to have side effects when taking Moviprep.
Among them, 28 people (0.89%) have Flatulence.

Among these 28 people:

How long have people been on Moviprep when they have Flatulence? *

What is the gender of people who have Flatulence when taking Moviprep? *

female: 75 %
male: 25 %

What is the age of people who have Flatulence when taking Moviprep? *

What are other drugs people take besides Moviprep? *

What are other side effects people have besides Flatulence? *

Abdominal Distension: 11 people, 39.29%
Diarrhea: 8 people, 28.57%
Headache (pain in head): 7 people, 25.00%
Gastrointestinal Sounds Abnormal: 6 people, 21.43%
Abdominal Pain: 5 people, 17.86%
Abdominal Pain Upper: 5 people, 17.86%
Nausea And Vomiting: 5 people, 17.86%
Drug Ineffective: 4 people, 14.29%
Abdominal Discomfort: 4 people, 14.29%
Irritable Bowel Syndrome: 4 people, 14.29%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 10.71%
Depression: 2 people, 7.14%
Drug Dependence: 1 person, 3.57%
Blood Pressure Abnormal: 1 person, 3.57%
Blood Testosterone Abnormal: 1 person, 3.57%
Bronchial Disorder: 1 person, 3.57%
Colitis (inflammation of colon): 1 person, 3.57%
Constipation: 1 person, 3.57%
Diabetes: 1 person, 3.57%
Diarrhea: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and have Flatulence?

- Check whether Flatulence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Moviprep:

Moviprep (3,173 reports)

Flatulence treatments and more:

Flatulence (70,666 reports)

How severe was Flatulence and when was it recovered:

Flatulence in Moviprep

Expand to all the drugs that have ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate:

Flatulence and drugs with ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Moviprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Flatulence:

Flatulence (1,792 drugs)

Browse all the conditions that are associated with Flatulence:

Flatulence (1,889 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate (the active ingredients of Moviprep) and Moviprep (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.